Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST

This study is currently recruiting participants.

Verified October 2011 by Radboud University

Study NCT00979329 Information provided by Radboud University

First Received on September 17, 2009. Last Updated on October 6, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Renal Cell Cancer
Colorectal Cancer
GIST

Additional conditions recognized in this trial

Carcinoma, Renal Cell
Colorectal Neoplasms
Depression
Depressive Disorder
Fatigue
Gastrointestinal Stromal Tumors

Interventions listed in this trial

Questionnaires

Additional drug interventions recognized in this trial

Sorafenib
Sunitinib

More general drug interventions related to this trial

Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Therapeutic Uses

Sponsors listed in this trial

Radboud University

Back to top of Main Content